HRP940367A2 - Tumoricidebis-imide polycyclic and heterocyclic chromophores useful as tumoricidals - Google Patents

Tumoricidebis-imide polycyclic and heterocyclic chromophores useful as tumoricidals Download PDF

Info

Publication number
HRP940367A2
HRP940367A2 HR08/080,862A HRP940367A HRP940367A2 HR P940367 A2 HRP940367 A2 HR P940367A2 HR P940367 A HRP940367 A HR P940367A HR P940367 A2 HRP940367 A2 HR P940367A2
Authority
HR
Croatia
Prior art keywords
dicarboximido
azaphenanthrene
propylamino
nitro
nmr
Prior art date
Application number
HR08/080,862A
Other languages
English (en)
Croatian (hr)
Inventor
Artur David Patten
Gregory Pacofsky
Steven Paul Seitz
Emeka Amaechi Akamike
Robert Joseph Cherney
Robert Frank Kaltenbach
Michael James Orwat
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of HRP940367A2 publication Critical patent/HRP940367A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/28—Pyronines ; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B15/00—Acridine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/002—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being condensed in peri position and in 1-2 or 2-3 position
    • C09B5/004—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being condensed in peri position and in 1-2 or 2-3 position only O-containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C09B57/08—Naphthalimide dyes; Phthalimide dyes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR08/080,862A 1993-06-24 1994-06-23 Tumoricidebis-imide polycyclic and heterocyclic chromophores useful as tumoricidals HRP940367A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/080,862 US5416089A (en) 1993-06-24 1993-06-24 Polycyclic and heterocyclic chromophores for bis-imide tumoricidals

Publications (1)

Publication Number Publication Date
HRP940367A2 true HRP940367A2 (en) 1997-04-30

Family

ID=22160120

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/080,862A HRP940367A2 (en) 1993-06-24 1994-06-23 Tumoricidebis-imide polycyclic and heterocyclic chromophores useful as tumoricidals

Country Status (19)

Country Link
US (2) US5416089A (en:Method)
EP (1) EP0705250A1 (en:Method)
JP (1) JPH08511802A (en:Method)
KR (1) KR960703113A (en:Method)
CN (1) CN1125943A (en:Method)
AU (1) AU7171294A (en:Method)
BR (1) BR9407265A (en:Method)
CA (1) CA2165765A1 (en:Method)
CZ (1) CZ336795A3 (en:Method)
FI (1) FI956231A0 (en:Method)
HR (1) HRP940367A2 (en:Method)
HU (1) HUT75121A (en:Method)
IL (1) IL110033A0 (en:Method)
NO (1) NO955257L (en:Method)
PL (1) PL312272A1 (en:Method)
SK (1) SK163095A3 (en:Method)
TW (1) TW263506B (en:Method)
WO (1) WO1995000490A1 (en:Method)
ZA (1) ZA944370B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
US5641782A (en) * 1995-02-16 1997-06-24 The Dupont Merck Pharmaceutical Company 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
FR2751655B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1053237B1 (en) * 1998-02-04 2003-07-02 The Board Of Regents, The University Of Texas System Inhibition of human telomerase by a g-quadruplex-interaction compound
ES2191532B1 (es) * 2001-05-28 2005-02-16 Fundacion Universitaria San Pablo - Ceu Derivados de naftalimidas heterociclicas como agentes antiproliferativos.
US20040082788A1 (en) * 2002-07-08 2004-04-29 Chemgenex Therapeutics, Inc. Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
US20050192312A1 (en) * 2004-01-30 2005-09-01 Brown Dennis M. Naphthalimide dosing by N-acetyl transferase genotyping
CA2569279A1 (en) * 2004-06-04 2005-12-15 Chemgenex Pharmaceuticals, Inc. Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors
JP4993645B2 (ja) 2004-12-01 2012-08-08 ジェネンテック， インコーポレイテッド 抗体薬剤結合体および方法
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
KR20100074288A (ko) * 2007-10-22 2010-07-01 오키드 리서치 레버라토리즈 리미티드 히스톤 디아세틸라제 억제제
CN101638389B (zh) * 2008-03-03 2012-09-05 河南大学 一种含萘酰亚胺结构的多胺衍生物及其制备方法和应用
US9060776B2 (en) 2009-10-09 2015-06-23 Ethicon Endo-Surgery, Inc. Surgical generator for ultrasonic and electrosurgical devices
CN106167490B (zh) * 2016-08-10 2018-11-09 大连理工大学 一类含吲哚的咪唑并萘酰亚胺类衍生物及其合成和应用
CZ308568B6 (cs) 2018-12-03 2020-12-09 Univerzita Karlova Naftalimidofurany pro aplikace v molekulární biologii
JP6884920B2 (ja) * 2019-04-02 2021-06-09 旭化成株式会社 錠剤の保存安定性を向上させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604827A1 (de) * 1986-02-15 1987-08-20 Bayer Ag Elektrophotographische toner
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5290931A (en) * 1990-02-21 1994-03-01 Hoechst Mitsubishi Kasei Co., Ltd. Water-insoluble naphthalic acid imide dyestuffs
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
US5206250A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amide and thioamide linkers as anticancer agents

Also Published As

Publication number Publication date
US5585382A (en) 1996-12-17
BR9407265A (pt) 1996-10-01
PL312272A1 (en) 1996-04-15
ZA944370B (en) 1996-01-04
TW263506B (en:Method) 1995-11-21
HU9503759D0 (en) 1996-02-28
EP0705250A1 (en) 1996-04-10
CA2165765A1 (en) 1995-01-05
CN1125943A (zh) 1996-07-03
IL110033A0 (en) 1994-10-07
KR960703113A (ko) 1996-06-19
FI956231L (fi) 1995-12-22
US5416089A (en) 1995-05-16
AU7171294A (en) 1995-01-17
JPH08511802A (ja) 1996-12-10
FI956231A7 (fi) 1995-12-22
FI956231A0 (fi) 1995-12-22
HUT75121A (en) 1997-04-28
SK163095A3 (en) 1996-09-04
WO1995000490A1 (en) 1995-01-05
NO955257D0 (no) 1995-12-22
CZ336795A3 (en) 1996-06-12
NO955257L (no) 1996-02-26

Similar Documents

Publication Publication Date Title
HRP940367A2 (en) Tumoricidebis-imide polycyclic and heterocyclic chromophores useful as tumoricidals
ES2587013T3 (es) Derivados de ciclohexano espirocíclicos
DE60014079T2 (de) Substituierte heterocyclisch kondensierte Gammacarboline
BR112020022936A2 (pt) derivados de tetra-hidro-imidazo[4,5-c]piridina como imunomoduladores de pd-l1
US20040214808A1 (en) Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
TW201833102A (zh) 作為ehmt2抑制劑之胺取代的雜環化合物及其使用方法
CA2879789A1 (en) Fused pyrimidines as inhibitors of p97 complex
EA019027B1 (ru) Производные флуорена, содержащие их композиции и применение
TW201124378A (en) Indole compounds and pharmaceutical use thereof
CA3184282A1 (en) Composition of compounds that modulate cell metabolism and methods of use
CN108794486A (zh) 稠环基酮类衍生物、其制备方法及其在医药上的应用
TW200918061A (en) Imino-indeno[1,2-c]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same
NZ560354A (en) Androgen receptor modulator compounds and methods
CA2615700C (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
KR20090080948A (ko) 신규한 플루오렌 유도체, 이를 함유하는 조성물, 및 단백질 샤페론 ｈｓｐ90의 억제제로서 그의 용도
AU2003217373B2 (en) Novel tyloindicines and related processes, pharmaceutical compositions and methods
CA2460126A1 (en) Tricyclic indole derivatives as 5-ht ligands
CA2220509C (en) Fused polycyclic heterocycle derivatives
US5952335A (en) Fused polycyclic heterocycle derivatives
US5641782A (en) 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
JPS63500518A (ja) 多環式キノリン、ナフチリジンおよびピラジノピリジン誘導体
JPH11501004A (ja) 三環系誘導体及びそれらの抗ガン剤としての使用
CN120757535A (zh) 含氧代吡啶并氧代脂肪环结构的化合物及其医药用途
WO2024210198A1 (ja) 新規なｂ０ａｔ１阻害剤
BR112024023625B1 (pt) Compostos inibidores de ptpn2, composição farmacêutica que compreende os ditos compostos e usos terapêuticos dos mesmos

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODBC Application rejected